ALP — Alpha Compute Share News
0.000.00%
Last trade - 00:00- $4.68m
- $2.32m
- $0.10m
Brief: Portage Biotech Announces Results For Fiscal Quarter Ended December 31, 2022
Portage Biotech Inc reports results for the quarter ended in December - Earnings Summary
Portage Biotech Inc expected to post a loss of 23 cents a share - Earnings Preview
Portage Biotech Inc reports results for the quarter ended in September - Earnings Summary
Brief: Portage Biotech Announces Results For Fiscal Quarter Ended September 30, 2022
Portage Biotech Inc expected to post a loss of 29 cents a share - Earnings Preview
Portage Biotech rises on Merck collaboration for cancer therapy
Brief: Portage Biotech Announces Clinical Trial Collaboration Agreement With Merck
Brief: Portage Biotech Provides Research And Development Update
Brief: Portage Biotech Reports Quarterly Loss Per Share Of $0.13
Brief: Portage Biotech Inc - CEO Dr. Ian Walters to take on additional responsibility as chairman of board
Brief: Portage Biotech Acquires Outstanding Minority Interest Of Invariant Natural Killer T Cell (Inkt) Agonist Platform
Brief: Portage Biotech Announces Acquisition Of Four Candidates Targeting The Adenosine Pathway
NASDAQ RESUMED AT 09:48 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:39 AM
Brief: Portage Biotech Enters Agreement With U.S. National Cancer Institute And Stimunity
Brief: Portage Biotech Provides Update On Clinical-Stage, Development Programs
Brief: Portage Biotech Announces Results For Q3 Of 2022 Fiscal Year
Brief: Portage Biotech Reports Financial Results For Q2 2022